RajeshTota-MaharajMDMBA FACP FACC RPVI

Echocardiography, Interventional Cardiology, Non-Invasive Cardiology, Preventive Cardiology

Interventional Cardiologist, Section Chair of Cardiology, Advent Health East Orlando Clinical Researcher, The Johns Hopkins Ciccarone Center for Preventive Cardiology, Baltimore, MD

Join to view full profile

Dr. Tota-Maharaj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tota-Maharaj's full profile

Already have an account?

Office
258 S Chickasaw Trl
Ste 310
Orlando, FL 32825
Phone+1 407-303-6588

Fax+1 407-303-6592

Education & Training

Florida International UniversityMBA, Corporate Masters in Business Administration, 2018 - 2020
Johns Hopkins UniversityFellowship, Interventional Cardiology, 2015 - 2016
Danbury HospitalFellowship, Cardiovascular Disease, 2012 - 2015
Greater Baltimore Medical CenterResidency, Internal Medicine, 2009 - 2012
University of the West Indies Faculty of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2016 - 2026

Publications & Presentations

PubMed

3 citations
A Comparative Review of Established Diets for Prevention of Cardiovascular Disease and Newer Dietary Strategies
Gustavo A Vargas, Jilla R Azarbal, Rajesh Tota-Maharaj
Current Problems in Cardiology. 2021-03-01
The shearing stress of baseball-spontaneous coronary artery dissection in a male athlete.
Gustavo A Vargas, Jilla R Azarbal, Marco Mejia, Rajesh Tota-Maharaj
Annales De Cardiologie Et D'angeiologie. 2021-02-01
19 citations
Breast Arterial Calcium: A Game Changer in Women's Cardiovascular Health?
Renato Quispe, Mahmoud Al-Rifai, Philip A. Di Carlo, Erin D. Michos, Nivee Amin
JACC. Cardiovascular Imaging. 2019-12-01

Authored Content

The Heart of the MatterFebruary 2019
The JUPITER trial and statins in primary prevention: Unequivocal benefit, or still a debatable issue?December 2010